22.418 articles found

[Pharmacokinetic comparison of Sinemet and Grifoparkin (levodopa/carbidopa 250/25 mg) in Parkinson s disease: a single dose study].

Chaná P, Fierro A, Reyes-Parada M, Sáez-Briones P.

Rev Med Chil · 2003-06-01

DOI: 10.4067/s0034-98872003000600006PMID: 12942590

Low-dose cyproterone acetate treatment of sexual acting out in men with dementia.

Haussermann P, Goecker D, Beier K, Schroeder S.

Int Psychogeriatr · 2003-06-01

DOI: 10.1017/s104161020300886xPMID: 14620076

Advances in pharmacotherapy of psychotic disorders in the elderly.

Kirkwood CK, Givone DM.

Consult Pharm · 2003-06-01

PMID: 16563063

[The use of embryonic stem cells for medical-therapeutical purposes: a study of attitudes among Icelandic physicians, lawyers and clergymen.].

Oskarsson T, Guðmundsson F, Sigurðsson JA, Getz L, Arnason V.

Laeknabladid · 2003-06-01

PMID: 16940596

COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF AMYLOID DISEASES AND SYNUCLEINOPATHIES SUCH AS ALZHEIMER S DISEASE, TYPE 2 DIABETES, AND PARKINSON S DISEASE

SNOW Alan D., NGUYEN Beth P., CASTILLO Gerardo M., SANDERS Virginia J., LAKE Thomas P., LARSEN Lesley, WEAVERS Rex T., LORIMER Stephen D., LARSEN David S., COFFEN David L..

· 2003-05-30

Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes, and parkinson's disease

SNOW ALAN D, NGUYEN BETH P, CASTILLO GERARDO M, SANDERS VIRGINIA J, LAKE THOMAS P, LARSEN LESLEY, WEAVERS REX T, LORIMER STEPHEN D, LARSEN DAVID S, COFFEN DAVID L, COFFEN CHARLOTTE, COFFEN LEGAL REPRESENTATIVE CHARLOTTE.

· 2003-05-30

Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes, and parkinson's disease

SNOW ALAN D, NGUYEN BETH P, CASTILLO GERARDO M, SANDERS VIRGINIA J, LAKE THOMAS P, LARSEN LESLEY, WEAVERS REX T, LORIMER STEPHEN D, LARSEN DAVID S, COFFEN DAVID L, COFFEN CHARLOTTE, COFFEN LEGAL REPRESENTATIVE CHARLOTTE.

· 2003-05-30

Therapeutic and prophylactic use of reduced forms of pharmaceutical compounds

WUELFERT ERNST, ATKINSON ANTHONY, SALOMON ANDRES MARC.

· 2003-05-29

Neuropathological and behavioral changes induced by various treatment paradigms with MPTP and 3-nitropropionic acid in mice: towards a model of striatonigral degeneration (multiple system atrophy).

Stefanova N, Puschban Z, Fernagut PO, Brouillet E, Tison F, Reindl M, Jellinger KA, Poewe W, Wenning GK.

Acta Neuropathol · 2003-05-23

DOI: 10.1007/s00401-003-0717-yPMID: 12764627

Method for screening for anti-amyloidogenic properties and method for treatment of neurodegenerative disease

MASLIAH ELIEZER, ROCKENSTEIN EDWARD, HASHIMOTO MAKOTO, MALLORY LEGAL REPRESENTATIVE HERSEY.

· 2003-05-22

Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function.

Bézard E, Ferry S, Mach U, Stark H, Leriche L, Boraud T, Gross C, Sokoloff P.

Nat Med · 2003-05-12

DOI: 10.1038/nm875PMID: 12740572

Therapeutic agents useful for treating pain

GHARAGOZLOO PARVIZ, ISLAM KHONDAKER, KYLE DONALD J, SUN QUN, TAFESSE LAYKEA, WHITEHEAD JOHN WILLIAM FRANK, YANG JI, ZHOU XIAOMING.

· 2003-05-02